
|Articles|October 29, 2021
Daily OTC Pearl: Omeprazole (Prilosec)
Author(s)Saro Arakelians, PharmD
Prilosec treats duodenal ulcer and gastric ulcer in adults, treatment of gastroesophageal reflux disease (GERD) in adults and children, and maintenance of healing of erosive esophagitis.
Advertisement
OTC/Lifestyle Pearl of the Day: Omeprazole (Prilosec)
Indication: Prilosec is a proton pump inhibitor indicated for the treatment of duodenal ulcer and gastric ulcer in adults, treatment of gastroesophageal reflux disease in adults and children, and maintenance of healing of erosive esophagitis.
Insight:
- Dosing: Includes 20mg, 40mg, and 60mg.
- Dosage form: 10 mg, 20 mg and 40 mg. Delayed-release oral suspension 2.5 mg or 10 mg.
- Adverse events (AEs): Most common AEs in adults (incidence ≥ 2%) are headache, abdominal pain, nausea, diarrhea, vomiting, and flatulence.
- Mechanism of action: Omeprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+ /K+ ATPase enzyme system at the secretory surface of the gastric parietal cell.
- Manufacturer: AstraZeneca
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
4
Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer
5




























































































































